EFFICACY OF INTRAVESICAL NADOFARAGENE FIRADENOVEC FOR PATIENTS WITH BCG-UNRESPONSIVE CARCINOMA IN SITU OF THE BLADDER: 36-MONTH FOLLOW-UP FROM A PHASE 3 TRIAL
S. Boorjian, Vikram M. Narayan, V. Master, Badrinath R. Konety, Neal D. Shore, Ashish M. Kamat, C. Dinney, T. Bivalacqua, Max R. Kates, Jeffrey S. Montgomery, Seth Lerner, P. Crispen, Gary D. Steinberg, P. Agarwal, A. Schuckman, R. Svatek, B. Lane, Lawrence Karsh, Marc Bjurlin, Gordon A. Brown, Y. Lotan, Brant A. Inman, Michael B. Williams, M. S. Cookson, Sam S. Chang, Eric H. Kim, Alex Sankin, Michael A. O'Donnell, Jørn S. Jakobsen, Kristian Juul
{"title":"EFFICACY OF INTRAVESICAL NADOFARAGENE FIRADENOVEC FOR PATIENTS WITH BCG-UNRESPONSIVE CARCINOMA IN SITU OF THE BLADDER: 36-MONTH FOLLOW-UP FROM A PHASE 3 TRIAL","authors":"S. Boorjian, Vikram M. Narayan, V. Master, Badrinath R. Konety, Neal D. Shore, Ashish M. Kamat, C. Dinney, T. Bivalacqua, Max R. Kates, Jeffrey S. Montgomery, Seth Lerner, P. Crispen, Gary D. Steinberg, P. Agarwal, A. Schuckman, R. Svatek, B. Lane, Lawrence Karsh, Marc Bjurlin, Gordon A. Brown, Y. Lotan, Brant A. Inman, Michael B. Williams, M. S. Cookson, Sam S. Chang, Eric H. Kim, Alex Sankin, Michael A. O'Donnell, Jørn S. Jakobsen, Kristian Juul","doi":"10.1016/j.urolonc.2024.01.201","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":506909,"journal":{"name":"Urologic Oncology: Seminars and Original Investigations","volume":"62 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologic Oncology: Seminars and Original Investigations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.urolonc.2024.01.201","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}